Artificial intelligence-driven cardiac magnetic resonance imaging solution approved by US Food and Drug Administration

Benshaw found that many friends were interested in information that artificial intelligence-driven cardiac magnetic resonance imaging solutions had been approved by the U.S. Food and Drug Administration. Benshaw collated and shared some information about the artificial intelligence-driven cardiac magnetic resonance imaging solution that is being approved by the Food and Drug Administration.

HeartVista, a medical technology company headquartered in Los Altos, Calif., has received FDA approval to launch an one-click heart MRI solution powered by AI.

According to HeartVista, "one-click" removes many of the limitations of heart MRI, making it "simple, time-saving, economical and highly consistent."

"patients across the country can now use the only AI-guided cardiac MRI, which will provide continuous imaging through an automated process, reduce errors and simplify scanning operations," HeartVista CEO Itamar Kandel said in a prepared statement. " Our AI solution generates clear, accurate and feasible real-time data for cardiologists. We believe that this will improve the nursing level of cardiac imaging, enhance the experience and access of patients, and improve the therapeutic effect of patients. "

Kandel also highlighted a study published in June 2019 in the New England Journal of Medicine that cardiac MRI was considered "the gold standard for heart diagnosis even compared to invasive replacement therapy".